Product Specifications

Key Features

• Rapid-Melt Technology: Dissolves quickly on the tongue, facilitating easy administration during bouts of nausea when swallowing fluids is difficult.

• Unit-Dose Packaging: Provided in convenient blister packs for hygienic dispensing and accurate dose tracking in clinical and home environments.

• Pediatric Friendly: The 4 mg strength is the standard dose for pediatric patients and adults requiring lower dosage increments.

• High Stability: Glenmark’s formulation ensures consistent potency and rapid onset of anti-emetic effects.

• Prescription Strength: Provides professional-grade relief from moderately emetogenic chemotherapy-induced nausea and vomiting (CINV).

Clinical Applications

• CINV Prevention: Used for patients undergoing chemotherapy that causes moderate nausea.

• PONV Management: Prevention and treatment of postoperative nausea and vomiting.

• Radiation Therapy: Prevention of nausea in patients receiving radiotherapy.

• Gastroenteritis: Commonly used off-label in emergency departments to control vomiting and aid oral rehydration.

⚠️ Usage Note: Do not attempt to push the tablet through the blister foil. Peel back the foil with dry hands, place the tablet on the tongue, and allow it to dissolve.

⚠️ Safety Alert: Contains Phenylalanine. This product contains aspartame. Patients with Phenylketonuria (PKU) should be informed.

⚠️ Clinical Warning: Monitor for QT prolongation on EKG, particularly in patients with electrolyte imbalances or those taking other medications that prolong the QT interval.